Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94


Natural history and imaging in men with high genetic risk for developing prostate cancer.

Dahut WL, Couvillon A, Pinto PA, Turkbey B, Karzai F.

Can J Urol. 2019 Oct;26(5S2):7-8.


Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening.

Vertosick EA, Poon BY, Vickers AJ.

J Urol. 2014 Sep;192(3):724-8. doi: 10.1016/j.juro.2014.03.032. Epub 2014 Mar 15.


Epidemiology of prostate cancer.

Crawford ED.

Urology. 2003 Dec 22;62(6 Suppl 1):3-12. Review.


Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.

US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, Doubeni CA, Ebell M, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Siu AL, Tseng CW.

JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710. Erratum in: JAMA. 2018 Jun 19;319(23):2443.


Characterization of germline copy number variation in high-risk African American families with prostate cancer.

Ledet EM, Hu X, Sartor O, Rayford W, Li M, Mandal D.

Prostate. 2013 May;73(6):614-23. doi: 10.1002/pros.22602. Epub 2012 Oct 11.


Family history, perceived risk, and prostate cancer screening among African American men.

Bloom JR, Stewart SL, Oakley Girvan I, Banks PJ, Chang S.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2167-73. Erratum in: Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):388. Oakley-Girvans, Ingrid [corrected to Oakley-Girvan, Ingrid].


Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.

Hughes L, Zhu F, Ross E, Gross L, Uzzo RG, Chen DY, Viterbo R, Rebbeck TR, Giri VN.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):53-60. doi: 10.1158/1055-9965.EPI-11-0727. Epub 2011 Dec 5.


Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.

Giri VN, Egleston B, Ruth K, Uzzo RG, Chen DY, Buyyounouski M, Raysor S, Hooker S, Torres JB, Ramike T, Mastalski K, Kim TY, Kittles R.

Cancer Prev Res (Phila). 2009 Mar;2(3):244-50. doi: 10.1158/1940-6207.CAPR-08-0150. Epub 2009 Feb 24.


Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.

Nicolosi P, Ledet E, Yang S, Michalski S, Freschi B, O'Leary E, Esplin ED, Nussbaum RL, Sartor O.

JAMA Oncol. 2019 Apr 1;5(4):523-528. doi: 10.1001/jamaoncol.2018.6760.


Prostate cancer epidemiology in the United States.

Brawley OW.

World J Urol. 2012 Apr;30(2):195-200. doi: 10.1007/s00345-012-0824-2. Epub 2012 Apr 5. Review.


African American Participation in Oncology Clinical Trials--Focus on Prostate Cancer: Implications, Barriers, and Potential Solutions.

Ahaghotu C, Tyler R, Sartor O.

Clin Genitourin Cancer. 2016 Apr;14(2):105-16. doi: 10.1016/j.clgc.2015.12.003. Epub 2015 Dec 17. Review.


Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):949-57.


Genetic Hitchhiking and Population Bottlenecks Contribute to Prostate Cancer Disparities in Men of African Descent.

Lachance J, Berens AJ, Hansen MEB, Teng AK, Tishkoff SA, Rebbeck TR.

Cancer Res. 2018 May 1;78(9):2432-2443. doi: 10.1158/0008-5472.CAN-17-1550. Epub 2018 Feb 8.


Race/ethnicity and the perception of the risk of developing prostate cancer.

Shavers VL, Underwood W, Moser RP.

Am J Prev Med. 2009 Jul;37(1):64-7. doi: 10.1016/j.amepre.2009.03.007. Epub 2009 May 7.


Men with a susceptibility to prostate cancer and the role of genetic based screening.

Eeles R, Ni Raghallaigh H.

Transl Androl Urol. 2018 Feb;7(1):61-69. doi: 10.21037/tau.2017.12.30. Review.


Prostate Cancer Screening Guidelines for African American Veterans: A New Perspective.

Reddy A, Roberts R, Shenoy D, Packianathan S, Giri S, Vijayakumar S.

J Natl Med Assoc. 2018 Nov 5. pii: S0027-9684(18)30284-0. doi: 10.1016/j.jnma.2018.10.010. [Epub ahead of print]


Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR.

J S C Med Assoc. 2006 Aug;102(7):241-9. Review.


Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men.

Hughes L, Ruth K, Rebbeck TR, Giri VN.

Prostate Cancer Prostatic Dis. 2013 Dec;16(4):308-14. doi: 10.1038/pcan.2013.36. Epub 2013 Sep 24.

Supplemental Content

Support Center